VICKS Nasivin 0.05 %, solution pour pulvérisation nasale
7680546130084
CH-54613
Lösung
Associated product:
Vicks Nasivin, spray nasal 0.05 % , fl 10 ml
1 / 2
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- ml
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
22.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 7.50
Specialties list
Yes
Generic
No
SL addition date:
01/02/2008
Authorization holder
Procter & Gamble International
1213 Lancy
Authorization information
- Swissmedic authorization number
- 54613
- Drug name
- VICKS Nasivin, solution pour pulvérisation nasale
- Galenic form
- NASSL
- ATC Code
- R01AA05
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 27/10/1998
- Authorization expiration date
- 31/12/9999
- IT Number
- 12.02.1.
- Domain
- Human medicine
Package details
- Description (FR)
- VICKS Nasivin 0.05 % nasal spray 0.5 mg 10 ml
- Description (DE)
- VICKS Nasivin 0.05 % Nasenspray 0.5 mg 10 ml
- Market launch
- 27/10/1998
- Narcotic (BTM)
- No